Do we need a new way to release groundbreaking research?

03/24/2013 | CardiovascularBusiness.com

The embargo process at cardiovascular medical meetings has come under fire in recent years, but the networking and educational benefits of the professional conclaves are better than ever, said SCAI fellow Dr. Ajay Kirtane of Columbia University Medical Center. Kirtane attributed embargo issues to the nature of digital communications and suggested a "novel format" for presenting trial results to the medical community and the press, either online or via a restricted call. "I am increasingly unsure that embargoed late-breaking clinical trials are necessarily driving meeting attendance," he said.

View Full Article in:

CardiovascularBusiness.com